Physician profile
Asha K Advani
NPI 1396869244
$642.61
in general payments reported to CMS, 2019-2025
12 companies · $40.32 in 2025
The $40.32 reported for 2025 was less than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $31.91 · 2020: $36.60 · 2021: $201 · 2022: $38.91 · 2023: $98.96 · 2024: $195 · 2025: $40.32.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $335.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $334.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kaleo, INC. | $152.48 | 2020-2024 | Auvi-Q |
| Beigene USA, INC. | $124.91 | 2021 | |
| Merck Sharp & Dohme LLC | $105.45 | 2021-2025 | Gardasil 9, Vaxneuvance, Vaxelis |
| Seqirus USA INC | $60.61 | 2021-2024 | Flucelvax, Fluad, Flucelvax Quadrivalent |
| Sanofi Pasteur INC. | $53.30 | 2019-2023 | |
| Pfizer INC. | $27.29 | 2023 | |
| Hologic Sales and Service, LLC | $24.91 | 2025 | Aptima |
| Aytu Biopharma, INC. | $21.17 | 2021 | |
| Vertical Pharmaceuticals, LLC | $19.99 | 2019 | |
| Phadia US INC. | $18.90 | 2024 | Immunocap |
| Sanofi-Aventis U.S. LLC | $16.83 | 2024 | |
| Ironshore Pharmaceuticals INC. | $16.77 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Asha Advani listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.